• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Understanding Patient Needs Regarding Adverse Drug Reaction Reporting Smartphone Applications: A Qualitative Insight from Saudi Arabia.了解患者对药物不良反应报告智能手机应用程序的需求:来自沙特阿拉伯的定性见解。
Int J Environ Res Public Health. 2021 Apr 7;18(8):3862. doi: 10.3390/ijerph18083862.
2
Exploring the knowledge, perception, and practice of community pharmacists in Saudi Arabia toward pharmacovigilance and adverse drug reaction reporting. A nationwide survey.探索沙特阿拉伯社区药剂师在药物警戒和药物不良反应报告方面的知识、认知和实践。全国性调查。
Sci Rep. 2024 Feb 27;14(1):4819. doi: 10.1038/s41598-024-55664-8.
3
Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.有利于沙特阿拉伯药剂师报告药物不良反应的因素。
Expert Opin Drug Saf. 2019 Aug;18(8):745-752. doi: 10.1080/14740338.2019.1632287. Epub 2019 Jul 11.
4
The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.加纳患者在药物不良反应报告中的贡献:一项定量和定性研究。
BMC Public Health. 2018 Dec 18;18(1):1384. doi: 10.1186/s12889-018-6285-9.
5
Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.沙特阿拉伯达曼医疗保健人员对药物警戒及药品不良反应报告流程的知识、实践与态度
Curr Drug Saf. 2018;13(1):21-25. doi: 10.2174/1574886313666171218123802.
6
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况:文献回顾、描述性和定性分析以及问卷调查。
Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.
7
The perspective of pharmacist on pharmacovigilance and adverse drug reaction reporting in Asir region, Saudi Arabia.沙特阿拉伯阿西尔地区药剂师对药物警戒和药品不良反应报告的看法。
Eur Rev Med Pharmacol Sci. 2023 Feb;27(4):1667-1680. doi: 10.26355/eurrev_202302_31410.
8
Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India.印度农村地区药物不良反应(ADR)监测和报告机制的现状和未来展望。
Curr Drug Saf. 2024;19(2):172-190. doi: 10.2174/1574886318666230428144120.
9
Medication safety knowledge, attitude, and practice among hospital pharmacists in tertiary care hospitals in Saudi Arabia: a multi-center study.沙特阿拉伯三级医院药剂师的用药安全知识、态度及实践:一项多中心研究。
Arch Public Health. 2021 Jul 12;79(1):130. doi: 10.1186/s13690-021-00616-1.
10
Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.在尼日利亚西南部伊巴丹的选定初级保健中心,卫生工作者和患者对药物不良反应报告的认知、知识、态度和实践。
BMC Health Serv Res. 2019 Dec 3;19(1):926. doi: 10.1186/s12913-019-4775-9.

引用本文的文献

1
Assessment of knowledge and perceptions of pharmacy students toward pharmacovigilance activities, and their predictors: a cross-sectional study in Palestine.巴勒斯坦药学专业学生对药物警戒活动的知识与认知评估及其预测因素:一项横断面研究
BMC Med Educ. 2025 Jul 17;25(1):1067. doi: 10.1186/s12909-025-07575-z.
2
Prevalence and factors associated with adverse drug reactions among patients on highly active antiretroviral therapy at a tertiary hospital in south western Uganda: A cross-sectional study.乌干达西南部一家三级医院接受高效抗逆转录病毒治疗的患者中药物不良反应的患病率及相关因素:一项横断面研究。
PLoS One. 2025 Apr 10;20(4):e0321015. doi: 10.1371/journal.pone.0321015. eCollection 2025.
3
Mycetoma managment: Therapeutic challenges and the role of pharmacovigilance.足菌肿的管理:治疗挑战与药物警戒的作用
PLoS Negl Trop Dis. 2025 Feb 20;19(2):e0012827. doi: 10.1371/journal.pntd.0012827. eCollection 2025 Feb.
4
Factors Associated with the Public's Intention to Report Adverse Drug Reactions to Community Pharmacists in the Makkah Region of Saudi Arabia: An Application of the Theory of Planned Behavior.沙特阿拉伯麦加地区公众向社区药剂师报告药品不良反应意愿的相关因素:计划行为理论的应用
Patient Prefer Adherence. 2024 Dec 11;18:2495-2506. doi: 10.2147/PPA.S495487. eCollection 2024.
5
Knowledge, Attitude, and Practice Regarding Pharmacovigilance and Barriers to Reporting Adverse Drug Reactions Among the General Population in Saudi Arabia.沙特阿拉伯普通人群对药物警戒的知识、态度和实践以及报告药物不良反应的障碍
Risk Manag Healthc Policy. 2024 Oct 29;17:2557-2572. doi: 10.2147/RMHP.S484223. eCollection 2024.
6
Patients and Stakeholders' Perspectives Regarding the Privacy, Security, and Confidentiality of Data Collected via Mobile Health Apps in Saudi Arabia: Protocol for a Mixed Method Study.患者和利益相关者对沙特阿拉伯通过移动健康应用程序收集的数据的隐私、安全和保密性的看法:一项混合方法研究的方案。
JMIR Res Protoc. 2024 May 22;13:e54933. doi: 10.2196/54933.
7
Factors that influence patient and public adverse drug reaction reporting: a systematic review using the theoretical domains framework.影响患者和公众不良药物反应报告的因素:使用理论领域框架进行的系统评价。
Int J Clin Pharm. 2023 Aug;45(4):801-813. doi: 10.1007/s11096-023-01591-z. Epub 2023 May 29.
8
Healthcare professionals' awareness, attitudes and practices towards pharmacovigilance and spontaneous adverse drug reaction reporting in Jazan Province, Saudi Arabia: A survey study.沙特阿拉伯吉赞省医疗保健专业人员对药物警戒和自发药品不良反应报告的认知、态度及做法:一项调查研究
Saudi Pharm J. 2023 Jun;31(6):979-988. doi: 10.1016/j.jsps.2023.04.021. Epub 2023 Apr 25.
9
The impact of crisis and disasters risk management in COVID-19 times: Insights and lessons learned from Saudi Arabia.新冠疫情时期危机与灾害风险管理的影响:来自沙特阿拉伯的见解与经验教训
Ethics Med Public Health. 2021 Sep;18:100705. doi: 10.1016/j.jemep.2021.100705. Epub 2021 Jul 16.

本文引用的文献

1
Factors that influence the intention to use mobile phone caller tunes for patient reporting of adverse drug reactions: a qualitative study.影响使用手机来电铃声进行药物不良反应患者报告意愿的因素:一项定性研究
Ther Adv Drug Saf. 2019 Sep 14;10:2042098619871190. doi: 10.1177/2042098619871190. eCollection 2019.
2
Knowledge and Barriers Among Physicians Toward Adverse Drug Reaction Reporting at a Tertiary Care Hospital in Saudi Arabia.沙特阿拉伯一家三级护理医院医生对药物不良反应报告的认知与障碍
Hosp Pharm. 2021 Aug;56(4):368-373. doi: 10.1177/0018578720910385. Epub 2020 Mar 4.
3
Opinions of patients with persistent asthma regarding the use of mobile applications for disease monitoring.持续性哮喘患者对使用移动应用程序进行疾病监测的看法。
Eur Ann Allergy Clin Immunol. 2021 Nov;53(6):267-276. doi: 10.23822/EurAnnACI.1764-1489.175. Epub 2020 Nov 13.
4
Pharmacovigilance in healthcare education: students' knowledge, attitude and perception: a cross-sectional study in Saudi Arabia.医疗保健教育中的药物警戒:学生的知识、态度和看法:沙特阿拉伯的一项横断面研究。
BMC Med Educ. 2020 Jul 2;20(1):210. doi: 10.1186/s12909-020-02116-2.
5
National Cross-Sectional Study of Community-Based Adverse Drug Reactions in Saudi Arabia.沙特阿拉伯基于社区的药物不良反应全国横断面研究。
Drugs Real World Outcomes. 2020 Jun;7(2):161-170. doi: 10.1007/s40801-020-00186-8.
6
SWEDEGENE-a Swedish nation-wide DNA sample collection for pharmacogenomic studies of serious adverse drug reactions.斯堪的纳维亚基因-一项用于药物基因组学研究严重药物不良反应的瑞典全国性 DNA 样本采集研究。
Pharmacogenomics J. 2020 Aug;20(4):579-585. doi: 10.1038/s41397-020-0148-3. Epub 2020 Jan 17.
7
Patients' Perceptions of mHealth Apps: Meta-Ethnographic Review of Qualitative Studies.患者对移动医疗应用的认知:定性研究的元民族志综述。
JMIR Mhealth Uhealth. 2019 Jul 10;7(7):e13817. doi: 10.2196/13817.
8
Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.有利于沙特阿拉伯药剂师报告药物不良反应的因素。
Expert Opin Drug Saf. 2019 Aug;18(8):745-752. doi: 10.1080/14740338.2019.1632287. Epub 2019 Jul 11.
9
Adverse Drug Reaction (ADR) as a Cause of Hospitalization at a Government Hospital in Saudi Arabia: A Prospective Observational Study.沙特阿拉伯一家政府医院中作为住院原因的药品不良反应:一项前瞻性观察研究。
Curr Drug Saf. 2019;14(3):192-198. doi: 10.2174/1574886314666190520105330.
10
Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi Arabia.沙特阿拉伯利雅得市公众对药品不良反应报告的认知与看法。
Saudi Pharm J. 2017 Sep;25(6):868-872. doi: 10.1016/j.jsps.2017.01.004. Epub 2017 Jan 25.

了解患者对药物不良反应报告智能手机应用程序的需求:来自沙特阿拉伯的定性见解。

Understanding Patient Needs Regarding Adverse Drug Reaction Reporting Smartphone Applications: A Qualitative Insight from Saudi Arabia.

作者信息

Kassem Lamyaa M, Alhabib Bushra, Alzunaydi Khaledah, Farooqui Maryam

机构信息

Department of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University, Unaizah 51911, Saudi Arabia.

出版信息

Int J Environ Res Public Health. 2021 Apr 7;18(8):3862. doi: 10.3390/ijerph18083862.

DOI:10.3390/ijerph18083862
PMID:33917014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8067764/
Abstract

BACKGROUND

A pragmatic shift in the healthcare sector characterized by moving from curative to preventive approaches highlights the role of pharmacovigilance in patient safety. There have been few published studies on patient reporting of adverse drug reactions (ADRs) in Saudi Arabia. This qualitative study aims to explore the community opinions and the need for patient-friendly smartphone applications (SPAs) to enhance their participation in ADR reporting.

METHODS

Purposeful sampling was followed to recruit study participants, a semi-structured interview guide was used to conduct interviews, and the saturation was reached after the 13th interviewer; no new information was obtained after two subsequent interviews. All the interviews were audio-recorded, transcribed verbatim, and analyzed by means of a standard content analysis framework.

RESULTS

As per the WHO guidelines, eleven participants were aware of the term "ADR". All the participants denied receiving any prior education and attending events about ADRs and were unaware of the Saudi FDA-ADR reporting systems. The use of technologies such as SPAs has been widely accepted with a high level of concern for data confidentiality and privacy.

CONCLUSIONS

These findings point out the need to build patient-oriented educational programs to increase their awareness of ADR reporting and to prioritize the use of artificial intelligence (AI) to be integrated in the Saudi healthcare system to develop future SPAs for improving both patient safety and signal detection of ADRs.

摘要

背景

医疗保健领域从治疗方法向预防方法的务实转变凸显了药物警戒在患者安全中的作用。沙特阿拉伯关于患者报告药物不良反应(ADR)的已发表研究很少。这项定性研究旨在探讨社区意见以及对方便患者的智能手机应用程序(SPA)的需求,以提高他们参与ADR报告的程度。

方法

采用目的抽样法招募研究参与者,使用半结构化访谈指南进行访谈,在第13次访谈后达到饱和;随后两次访谈未获得新信息。所有访谈均进行录音,逐字转录,并通过标准内容分析框架进行分析。

结果

根据世界卫生组织的指南,11名参与者知晓“ADR”一词。所有参与者均否认曾接受过任何关于ADR的先前教育或参加过相关活动,并且不了解沙特食品药品管理局的ADR报告系统。诸如SPA之类的技术的使用已被广泛接受,同时对数据保密性和隐私性高度关注。

结论

这些发现指出需要建立以患者为导向的教育项目,以提高他们对ADR报告的认识,并优先考虑在沙特医疗保健系统中使用人工智能(AI),以开发未来的SPA,从而提高患者安全性和ADR信号检测能力。